TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 16, No. 5 March 3, 2010
(The next issue will be on March 15, 2010)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1FcVwRCqxg9bzcgYryEbSHd/
Ananyeva NM, Lee TK, Jain N, Shima M, and Saenko EL (2009) Inhibitors in hemophilia A: Advances in elucidation of inhibitory mechanisms and in inhibitor management with bypassing agents. Semin Thromb Hemost 35:735-751.
http://www.ncbi.nlm.nih.gov/pubmed/20169510
Colin AA, Shafieian M, and Andreansky M (2010) Bronchoscopic instillation of activated recombinant factor VII to treat diffuse alveolar hemorrhage in a child. Pediatr Pulmonol
http://www.ncbi.nlm.nih.gov/pubmed/20187104
Flower O, Phillips LE, Cameron P, Gunn K, Dunkley S, Watts A, and Rajbhandari D (2010) Recombinant activated factor VII in liver patients: A retrospective cohort study from Australia and New Zealand. Blood Coagul Fibrinolysis
http://www.ncbi.nlm.nih.gov/pubmed/20182351
Franchini M, Manzato F, Salvagno GL, Montagnana M, Zaffanello M, and Lippi G (2009) Prophylaxis in congenital hemophilia with inhibitors: The role of recombinant activated factor VII. Semin Thromb Hemost 35:814-819.
http://www.ncbi.nlm.nih.gov/pubmed/20169518
Gross PL and Vaezzadeh N (2010) Tissue factor microparticles and haemophilia. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20171716
Hedner U (2010) History of rFVIIa therapy. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20188400
Hoffman M and Monroe DM (2010) Platelet binding and activity of recombinant factor VIIa. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20188401
Holroyd EW and Simari RD (2010) Interdependent biological systems, multi-functional molecules: The evolving role of tissue factor pathway inhibitor beyond anti-coagulation. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20185167
Key NS (2010) Analysis of tissue factor positive microparticles. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20189224
Koyama T (2010) [Analyses on activation and regulation of blood coagulation]. Rinsho Byori 58:45-57.
http://www.ncbi.nlm.nih.gov/pubmed/20169944
Le TV, Rumbak MJ, Liu SS, Alsina AE, van Loveren H, and Agazzi S (2010) Insertion of intracranial pressure monitors in fulminant hepatic failure patients: Early experience using recombinant factor VII. Neurosurgery 66:455-458.
http://www.ncbi.nlm.nih.gov/pubmed/20173540
Lee CJ, Chandrasekaran V, Wu S, Duke RE, and Pedersen LG (2010) Recent estimates of the structure of the factor VIIa (FVIIa)/tissue factor (TF) and factor Xa (FXa) ternary complex. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20156644
Levi M (2010) The coagulant response in sepsis and inflammation. Hamostaseologie 30:10-16.
http://www.ncbi.nlm.nih.gov/pubmed/20162247
Luo JG, Chen YD, Tian F, Wang CH, Lu Y, Yang XX, and Lu SZ (2009) [Effects of tissue factor pathway inhibitor-1 on no-reflow in a rabbit model.]. Zhonghua Xin Xue Guan Bing Za Zhi 37:1113-1118.
http://www.ncbi.nlm.nih.gov/pubmed/20193184
Maroney SA, Ellery PE, and Mast AE (2010) Alternatively spliced isoforms of tissue factor pathway inhibitor. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20176395
Monroe DM, Mackman N, and Hoffman M (2010) Wound healing in hemophilia B mice and low tissue factor mice. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20170942
Nakar C, Cooper DL, and Dimichele D (2010) Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: An analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008). Haemophilia
http://www.ncbi.nlm.nih.gov/pubmed/20158526
Obergfell A, Nichols T, and Ezban M (2010) Animal models of FVIIa gene expression: Their role in the future development of haemophilia treatment. Haemophilia 16 Suppl 2:24-27.
http://www.ncbi.nlm.nih.gov/pubmed/20132335
Ohkubo YZ, Morrissey JH, and Tajkhorshid E (2010) Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor. J Thromb Haemost
http://www.ncbi.nlm.nih.gov/pubmed/20180816
Pawlinski R and Mackman N (2010) Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20185165
Pendurthi UR and Rao LV (2010) Factor VIIa interaction with endothelial cells and endothelial cell protein C receptor. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20156643
Popescu NI, Lupu C, and Lupu F (2010) Role of PDI in regulating tissue factor: FVIIa activity. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20163832
Rowe AS and Turner RM (2010) Coagulation factor VIIa (recombinant) for warfarin-induced intracranial hemorrhage. Am J Health Syst Pharm 67:361-365.
http://www.ncbi.nlm.nih.gov/pubmed/20172985
Seoud M, Cheaib S, Birjawi G, Tawil A, and Jamali F (2010) Successful treatment of severe retro-peritoneal bleeding with recombinant factor VIIa in women with placenta percreta invading into the left broad ligament: Unusual repeated ante-partum intra-abdominal bleeding. J Obstet Gynaecol Res 36:183-186.
http://www.ncbi.nlm.nih.gov/pubmed/20178548
Shetty S, Bhandary YP, Shetty SK, Velusamy T, Shetty P, et al. (2010) Induction of tissue factor by urokinase in lung epithelial cells and in the lungs. Am J Respir Crit Care Med
http://www.ncbi.nlm.nih.gov/pubmed/20194819
Smock KJ, Crist RA, Hansen SJ, Rodgers GM, and Lehman CM (2010) Discard tubes are not necessary when drawing samples for specialized coagulation testing. Blood Coagul Fibrinolysis
http://www.ncbi.nlm.nih.gov/pubmed/20182348
Szecsi PB, Jorgensen M, Klajnbard A, Andersen MR, Colov NP, and Stender S (2010) Haemostatic reference intervals in pregnancy. Thromb Haemost 103:
http://www.ncbi.nlm.nih.gov/pubmed/20174768
Woodruff SI, Dougherty AL, Dye JL, Mohrle CR, and Galarneau MR (2010) Use of recombinant factor VIIA for control of combat-related haemorrhage. Emerg Med J 27:121-124.
http://www.ncbi.nlm.nih.gov/pubmed/20156864
Yagi S, Akaike M, Aihara KI, Ishikawa K, Iwase T, Ikeda Y, Soeki T, Yoshida S, Sumitomo-Ueda Y, Matsumoto T, and Sata M (2010) Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury. Hypertension
http://www.ncbi.nlm.nih.gov/pubmed/20194307
Zhang W, Wang J, Wang H, Tang R, Belcher JD, et al. (2010) Acadesine inhibits tissue factor induction and thrombus formation by activating the phosphoinositide 3-Kinase/Akt signaling pathway. Arterioscler Thromb Vasc Biol
http://www.ncbi.nlm.nih.gov/pubmed/20185792
____________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
